Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.40 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | MMP1 | P03956 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 2/20 | 0.37 |
| ▸ | MMP9 | P14780 | 2/20 | 0.37 |
| ▸ | MMP8 | P22894 | 2/20 | 0.37 |
| ▸ | MMP13 | P45452 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9578959 | 0.84 | CA2 (0.50) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL8142964 | 0.84 | CA2 (0.50) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL15200857 | 0.80 | AKR1B1 (0.50) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL28304649 | 0.73 | KDM4E (0.41) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL896933 | 0.72 | RAPGEF4 (0.56) | LMNACA2RAPGEF4CA1MMP1 | |
| SCHEMBL250285 | 0.72 | CA2 (0.62) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL2122562 | 0.72 | CA2 (0.62) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL18187419 | 0.72 | CA2 (0.62) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL8978700 | 0.72 | CA2 (0.62) | AKR1B1LMNAMAPTHTTCA2 | |
| SCHEMBL23988486 | 0.71 | AKR1B1 (0.39) | AKR1B1LMNAMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177442-B1 | Thermally activated delayed fluorescence material and organic light emitting diode display device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-11-16 | — | — | US | disclosed |
| US-20210336150-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-10-28 | — | — | US | disclosed |
| CN-109970715-B | Thermally activated delayed fluorescent material and organic light emitting diode display device | 武汉华星光电半导体显示技术有限公司 | 2020-10-16 | — | — | CN | disclosed |
| WO-2020191894-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT-EMITTING DIODE DISPLAY DEVICE | 武汉华星光电半导体显示技术有限公司 | 2020-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177442-B1 | Thermally activated delayed fluorescence material and organic light emitting diode display device | CCND1, CCND2, TRPA1 | AKR1B1 3604/4885LMNA 2286/4885MAPT 580/4885 |
| US-20210336150-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE | CCND1, CCND2, TRPA1 | AKR1B1 3604/4885LMNA 2286/4885MAPT 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.